HUP0201142A2 - Compound screening method - Google Patents

Compound screening method

Info

Publication number
HUP0201142A2
HUP0201142A2 HU0201142A HUP0201142A HUP0201142A2 HU P0201142 A2 HUP0201142 A2 HU P0201142A2 HU 0201142 A HU0201142 A HU 0201142A HU P0201142 A HUP0201142 A HU P0201142A HU P0201142 A2 HUP0201142 A2 HU P0201142A2
Authority
HU
Hungary
Prior art keywords
screening method
compound screening
compound
screening
Prior art date
Application number
HU0201142A
Other languages
Hungarian (hu)
Inventor
Thierry Bogaert
Gwladys Cuvillier
Christ Platteeuw
Philippe Verwaerde
Original Assignee
Devgen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9908670.4A external-priority patent/GB9908670D0/en
Application filed by Devgen Nv filed Critical Devgen Nv
Publication of HUP0201142A2 publication Critical patent/HUP0201142A2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
    • A01K67/0333—Genetically modified invertebrates, e.g. transgenic, polyploid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43526—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
    • G01N2333/4353—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes
    • G01N2333/43534—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
HU0201142A 1999-04-15 2000-04-14 Compound screening method HUP0201142A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12959699P 1999-04-15 1999-04-15
GBGB9908670.4A GB9908670D0 (en) 1999-04-15 1999-04-15 Compound screening method

Publications (1)

Publication Number Publication Date
HUP0201142A2 true HUP0201142A2 (en) 2002-08-28

Family

ID=26315417

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201142A HUP0201142A2 (en) 1999-04-15 2000-04-14 Compound screening method

Country Status (10)

Country Link
EP (1) EP1175506A2 (en)
JP (1) JP2002542466A (en)
AU (1) AU780574B2 (en)
CA (1) CA2365707A1 (en)
GB (1) GB2351151B (en)
HK (1) HK1030047A1 (en)
HU (1) HUP0201142A2 (en)
MX (1) MXPA01010175A (en)
PL (1) PL351432A1 (en)
WO (1) WO2000063427A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01001826A (en) 1998-08-21 2002-04-08 Union Biometrica Inc Instrument for selecting and depositing multicellular organisms and other large objects.
AU5299200A (en) * 1999-05-27 2000-12-18 Pharmacia & Upjohn Company A nematode drug screen for modulators of mammalian disorders
AU2001260140A1 (en) * 2000-03-22 2001-10-03 Avntis Pharma Deutschland Gmbh Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can be used in the treatment of the above disease states and identification of a nematode gene.
US7083947B2 (en) 2000-05-19 2006-08-01 Devgen Nv Assay techniques using nematode worms
GB0012229D0 (en) 2000-05-19 2000-07-12 Devgen Nv Lipid uptake assays
US20030134301A1 (en) * 2001-07-27 2003-07-17 Brooksbank Robert Alan Identification and use of molecules implicated in pain
US20030138803A1 (en) * 2001-07-27 2003-07-24 Brooksbank Robert Alan Identification and use of molecules implicated in pain
US20040058326A1 (en) * 2001-07-27 2004-03-25 Brooksbank Robert Alan Identification and use of molecules implicated in pain
ES2319972T3 (en) 2001-10-15 2009-05-18 E.I. Du Pont De Nemours And Company IMINOBENZOXAZINAS, IMINOBENZOTIAZINAS AND IMINOQUINAZOLINAS TO CONTROL INVERTEBRATE PESTS.
WO2005066357A1 (en) * 2004-01-05 2005-07-21 Mitsubishi Pharma Corporation Method of screening molecule associated with psychiatric disorder
KR100848790B1 (en) * 2006-12-27 2008-07-30 연세대학교 산학협력단 High screening method for nematicide to b. xylophilus, diplo- scapter and c. elegans
WO2011017319A1 (en) 2009-08-03 2011-02-10 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods of treating disorders associated with protein polymerization
US8809617B2 (en) * 2009-11-05 2014-08-19 The University of Pittsburgh—Of the Commonwealth System of Higher Education Automated high-content live animal drug screening using C. elegans
US9072772B2 (en) 2009-11-05 2015-07-07 University of Pittsburgh—of the Commonwealth System of Higher Education Methods of treating disorders associated with protein aggregation
KR101764832B1 (en) * 2015-04-27 2017-08-03 서울시립대학교 산학협력단 C. elegans with bli-3 activity knocked down for screening oxidative stress inducing material and oxidative stress inducing material screening method using the same
CN111066735A (en) * 2019-12-24 2020-04-28 深圳市铁汉生态环境股份有限公司 Feeding device for measuring feeding amount of insects
CN112379064B (en) * 2020-11-18 2021-08-13 浙江省林业科学研究院 Method for high-throughput screening of pine wood nematode inhibitor

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55153599A (en) * 1979-05-18 1980-11-29 Duskin Franchise Co Ltd Toxic test method of chemical substance by using nematode
WO1990009096A2 (en) * 1989-02-03 1990-08-23 Cambridge Neuroscience Research, Inc. Method of screening and classifying compounds
US6461854B1 (en) * 1995-03-28 2002-10-08 The General Hospital Corporation Methods of screening compounds useful for prevention of infection or pathogenicity
US7166270B1 (en) * 1995-03-28 2007-01-23 The Netherlands Cancer Institute Methods of screening compounds useful for prevention of infection or pathogenicity
GB9510944D0 (en) * 1995-05-31 1995-07-26 Bogaert Thierry Assays and processes for the identification of compounds which control cell behaviour,the compounds identified and their use in the control of cell behaviour
WO1997011956A1 (en) * 1995-09-27 1997-04-03 The Trustees Of Columbia University In The City Of New York IDENTIFICATION OF sel-12 AND USES THEREOF
WO1998051351A1 (en) * 1997-05-15 1998-11-19 The General Hospital Corporation Therapeutic and diagnostic tools for impaired glucose tolerance conditions
US6278039B1 (en) * 1997-05-28 2001-08-21 Axys Pharmaceuticals, Inc. C. elegans deletion mutants
US6329566B1 (en) * 1997-05-29 2001-12-11 The General Hospital Corporation Methods for the detection, treatment, and prevention of neurodegeneration
WO1999002684A1 (en) * 1997-07-09 1999-01-21 University Technology Corporation Methods of identifying and screening genes associated with increased longevity and slowed aging
WO1999002652A1 (en) * 1997-07-11 1999-01-21 The General Hospital Corporation Transgenic nematode model of triplet repeat neurological diseases
US6087153A (en) * 1997-07-24 2000-07-11 The Trustees Of Columbia University In The City Of New York Sel-10 and uses thereof
GB9826890D0 (en) * 1998-12-07 1999-01-27 Devgen Nv Method for screening compounds
AU2497400A (en) * 1999-01-06 2000-07-24 California Institute Of Technology Polycystic kidney disease gene homologs required for male mating behavior in nematodes and assays based thereon

Also Published As

Publication number Publication date
CA2365707A1 (en) 2000-10-26
PL351432A1 (en) 2003-04-22
HK1030047A1 (en) 2001-04-20
MXPA01010175A (en) 2002-04-09
EP1175506A2 (en) 2002-01-30
AU4137600A (en) 2000-11-02
WO2000063427A3 (en) 2001-12-06
AU780574B2 (en) 2005-04-07
GB0009358D0 (en) 2000-05-31
JP2002542466A (en) 2002-12-10
WO2000063427A2 (en) 2000-10-26
GB2351151B (en) 2001-07-25
GB2351151A (en) 2000-12-20

Similar Documents

Publication Publication Date Title
GB9920644D0 (en) Novel method
GB9925559D0 (en) Novel method
HUP0201142A2 (en) Compound screening method
GB9922352D0 (en) Screening method
GB9826890D0 (en) Method for screening compounds
GB9923075D0 (en) Screening method
EP1237001A4 (en) Screening method
GB0009363D0 (en) Compound screening method
AU6429000A (en) Screening method
GB2359361B (en) Compound screening method
GB9820988D0 (en) Screening method
GB9908676D0 (en) Method for screening compounds
GB9902696D0 (en) Screening methods
AU2872501A (en) Screening method
GB9930255D0 (en) Screening method
GB9908670D0 (en) Compound screening method
AU6726400A (en) Screening method
GB9918681D0 (en) Novel method
GB9912736D0 (en) Compound screening methods
GB9915225D0 (en) Screening method
GB9915226D0 (en) Screening method
GB9928430D0 (en) Screening
GB9904158D0 (en) Novel method
GB9922241D0 (en) Novel method
GB9911796D0 (en) Novel method